Smith TJ - Search Results

1

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.

Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, Brown JL, Skerry JC. Webb RP, et al. Among authors: smith tj, smith la. Toxins (Basel). 2017 Sep 3;9(9):269. doi: 10.3390/toxins9090269. Toxins (Basel). 2017. PMID: 28869522 Free PMC article.

2

Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.

Potter KJ, Bevins MA, Vassilieva EV, Chiruvolu VR, Smith T, Smith LA, Meagher MM. Potter KJ, et al. Protein Expr Purif. 1998 Aug;13(3):357-65. doi: 10.1006/prep.1998.0910. Protein Expr Purif. 1998. PMID: 9693060

3

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

Byrne MP, Smith TJ, Montgomery VA, Smith LA. Byrne MP, et al. Among authors: smith tj, smith la. Infect Immun. 1998 Oct;66(10):4817-22. doi: 10.1128/IAI.66.10.4817-4822.1998. Infect Immun. 1998. PMID: 9746584 Free PMC article.

4

Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib.

Marvaud JC, Smith T, Hale ML, Popoff MR, Smith LA, Stiles BG. Marvaud JC, et al. Infect Immun. 2001 Apr;69(4):2435-41. doi: 10.1128/IAI.69.4.2435-2441.2001. Infect Immun. 2001. PMID: 11254604 Free PMC article.

5

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Nowakowski A, Wang C, Powers DB, Amersdorfer P, Smith TJ, Montgomery VA, Sheridan R, Blake R, Smith LA, Marks JD. Nowakowski A, et al. Among authors: smith tj, smith la. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11346-50. doi: 10.1073/pnas.172229899. Epub 2002 Aug 12. Proc Natl Acad Sci U S A. 2002. PMID: 12177434 Free PMC article.

6

Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants.

Jensen MJ, Smith TJ, Ahmed SA, Smith LA. Jensen MJ, et al. Among authors: smith tj, smith la. Toxicon. 2003 May;41(6):691-701. doi: 10.1016/s0041-0101(03)00042-4. Toxicon. 2003. PMID: 12727273

7

Roads from vaccines to therapies.

Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. Smith LA, et al. Among authors: smith tj. Mov Disord. 2004 Mar;19 Suppl 8:S48-52. doi: 10.1002/mds.20009. Mov Disord. 2004. PMID: 15027054

8

Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.

Razai A, Garcia-Rodriguez C, Lou J, Geren IN, Forsyth CM, Robles Y, Tsai R, Smith TJ, Smith LA, Siegel RW, Feldhaus M, Marks JD. Razai A, et al. Among authors: smith tj, smith la. J Mol Biol. 2005 Aug 5;351(1):158-69. doi: 10.1016/j.jmb.2005.06.003. J Mol Biol. 2005. PMID: 16002090

9

Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD. Smith TJ, et al. Among authors: smith la. Infect Immun. 2005 Sep;73(9):5450-7. doi: 10.1128/IAI.73.9.5450-5457.2005. Infect Immun. 2005. PMID: 16113261 Free PMC article.

10

Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115.

Dux MP, Barent R, Sinha J, Gouthro M, Swanson T, Barthuli A, Inan M, Ross JT, Smith LA, Smith TJ, Webb R, Loveless B, Henderson I, Meagher MM. Dux MP, et al. Among authors: smith tj, smith la. Protein Expr Purif. 2006 Feb;45(2):359-67. doi: 10.1016/j.pep.2005.08.015. Epub 2005 Sep 20. Protein Expr Purif. 2006. PMID: 16214371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,734 results

Search Page